thromboview
mAbexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2005 (NCT00123734)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- ThrombinINHIBITOR
F2 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 99-MTC
Oral
No
Parenteral
No
Topical
No
Also known as
- 99mtc-di-80b3 fab'
- 99mtc-di-dd-3b6 22-80b3 fab'
- technetium 99m di-dd-3b6 22-80b3 fab'
- thromboview
- thromboview
- thromboview
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00123734 | Phase 2 | Mar 1, 2005 | Agen Biomedical, Hamilton Health Sciences Corporation |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Agen Biomedical | For profit | 1 | 1 | 1 | 2005 |
| Hamilton Health Sciences Corporation | Academic/Hospital | 1 | 0 | 1 | 2005 |
2 organizations
Page 1 / 1